Early auditory processing dysfunction in schizophrenia: Mechanisms and implications
- PMID: 36796472
- PMCID: PMC10106448
- DOI: 10.1016/j.neubiorev.2023.105098
Early auditory processing dysfunction in schizophrenia: Mechanisms and implications
Abstract
Schizophrenia is a major mental disorder that affects approximately 1% of the population worldwide. Cognitive deficits are a key feature of the disorder and a primary cause of long-term disability. Over the past decades, significant literature has accumulated demonstrating impairments in early auditory perceptual processes in schizophrenia. In this review, we first describe early auditory dysfunction in schizophrenia from both a behavioral and neurophysiological perspective and examine their interrelationship with both higher order cognitive constructs and social cognitive processes. Then, we provide insights into underlying pathological processes, especially in relationship to glutamatergic and N-methyl-D-aspartate receptor (NMDAR) dysfunction models. Finally, we discuss the utility of early auditory measures as both treatment targets for precision intervention and as translational biomarkers for etiological investigation. Altogether, this review points out the crucial role of early auditory deficits in the pathophysiology of schizophrenia, in addition to major implications for early intervention and auditory-targeted approaches.
Keywords: Auditory; Event-related potentials; NMDA receptor; Schizophrenia; Tone-matching.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflicts of interest statement DCJ holds equity in Glytech, AASI and NRX pharma. He has served as a consultant for SK Life Sciences, Biogen, Boehringer Ingelheim, Autifony and Anavex. He has received research support from Cerevance. He holds intellectual property for use of NMDAR agonists in treatment of schizophrenia; NMDAR antagonists for treatment of depression; neurophysiological measures for detection of amyloid deposition; and parcel-guided approaches to brain stimulation. JTK reports having received consulting payments within the last 24 months from Alphasights, Medscape, Putnam, techspert.io, Health Monitor, Third Bridge, MEDACorp, Trinity, Globaldata, GKA, Clearview, Clarivate, Health Advances, ECRI Institute, ExpertConnect, Acsel Health, Slingshot, Antheum, Guidepoint, L.E.K., SmartAnalyst, First Thought, Wedbush, Jefferies, Otsuka, Vox Neuro and Reckner. He has served on the MedinCell Psychiatry, Tolmar, Merck, Leal and the Karuna Advisory Boards. He has conducted clinical research supported by the NIMH, Sunovion, Roche, Cerevance, Click, Neurocrine, Corcept, Taisho and Boehringer Ingelheim within the last 24 months. He owns a small number of shares of common stock from GSK. AM serves as a consultant at Boehringer Ingelheim and Sumitomo and receives royalties from Oxford University Press. Other authors report no potential COI.
Figures





Similar articles
-
Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.Adv Neurobiol. 2024;40:411-451. doi: 10.1007/978-3-031-69491-2_15. Adv Neurobiol. 2024. PMID: 39562453 Review.
-
When doors of perception close: bottom-up models of disrupted cognition in schizophrenia.Annu Rev Clin Psychol. 2009;5:249-75. doi: 10.1146/annurev.clinpsy.032408.153502. Annu Rev Clin Psychol. 2009. PMID: 19327031 Free PMC article. Review.
-
Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.Brain. 2016 Dec;139(Pt 12):3281-3295. doi: 10.1093/brain/aww262. Brain. 2016. PMID: 27913408 Free PMC article. Clinical Trial.
-
Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jul;3(7):581-590. doi: 10.1016/j.bpsc.2018.02.002. Epub 2018 Feb 22. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. PMID: 29656951 Free PMC article. Review.
-
Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.Schizophr Bull. 2012 Sep;38(5):958-66. doi: 10.1093/schbul/sbs069. Schizophr Bull. 2012. PMID: 22987851 Free PMC article. Review.
Cited by
-
Why mismatch negativity continues to hold potential in probing altered brain function in schizophrenia.PCN Rep. 2023 Sep 24;2(3):e144. doi: 10.1002/pcn5.144. eCollection 2023 Sep. PCN Rep. 2023. PMID: 38867817 Free PMC article. Review.
-
Augmentation of learning in schizophrenia by D-serine is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study.Res Sq [Preprint]. 2023 May 19:rs.3.rs-2943290. doi: 10.21203/rs.3.rs-2943290/v1. Res Sq. 2023. Update in: Schizophr Res. 2023 Oct;260:205-208. doi: 10.1016/j.schres.2023.08.027. PMID: 37293030 Free PMC article. Updated. Preprint.
-
The Less Things Change, the More They Remain the Same: Impaired Neural Plasticity as a Critical Target for Drug Development in Neuropsychiatry.Adv Neurobiol. 2024;40:801-828. doi: 10.1007/978-3-031-69491-2_26. Adv Neurobiol. 2024. PMID: 39562464 Review.
-
Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.Adv Neurobiol. 2024;40:411-451. doi: 10.1007/978-3-031-69491-2_15. Adv Neurobiol. 2024. PMID: 39562453 Review.
-
A graph transformer-based foundation model for brain functional connectivity network.Pattern Recognit. 2026 Jan;169:111988. doi: 10.1016/j.patcog.2025.111988. Epub 2025 Jun 10. Pattern Recognit. 2026. PMID: 40688537
References
-
- Adam O, Blay M, Brunoni AR, Chang HA, Gomes JS, Javitt DC, Jung DU, Kantrowitz JT, Koops S, Lindenmayer JP, Palm U, Smith RC, Sommer IE, Valiengo L, Weickert TW, Brunelin J, Mondino M, 2022. Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Schizophr Bull - PMC - PubMed
-
- Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A, 1999. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry 156, 1646–1649. - PubMed
-
- Ahissar M, Lubin Y, Putter-Katz H, Banai K, 2006. Dyslexia and the failure to form a perceptual anchor. Nat Neurosci 9, 1558–1564. - PubMed
-
- Ajnakina O, Stubbs B, Francis E, Gaughran F, David AS, Murray RM, Lally J, 2021. Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies. Schizophr Res 231, 122–133. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous